Skip to content

Ultrasound-guided perivesicular nerve block with different concentrations of ropivacaine in femoral fracture surgery

Ultrasound-guided perivesicular nerve block with different concentrations of ropivacaine in femoral fracture surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065255
Enrollment
Unknown
Registered
2022-11-01
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral head replacement

Interventions

Blank group:None
0.3% ropivacaine group:PENG
0.4% ropivacaine group: PENG
0.5% ropivacaine group:PENG

Sponsors

The First Affiliated Hospital of Gannan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. From November 2022 to November 2023, 60 patients underwent elective unilateral femoral fracture surgery and received general anesthesia in the First Affiliated Hospital of Gannan Medical University; 2. Age 18-80 years; 3.ASA I~III, BMI18.5~23.9kg/m^2.

Exclusion criteria

Exclusion criteria: 1.Shock or coma; 2.Abnormal heart, lung, liver, kidney and coagulation function; 3.Intended block area infection, severe nerve injury of the block side limb; 4.Patients with a history of analgesic drugs for chronic pain, a history of psychotropic substance use, a history of radiotherapy and chemotherapy, and contraindications to NSAIDs; 5.Patients with allergies to local anesthetics such as lidocaine, ropivacaine and general anesthesia; 6.Patients and their families refused surgical anesthesia.

Design outcomes

Primary

MeasureTime frame
Sufentanil dosage;NRS score;

Secondary

MeasureTime frame
Patient satisfaction;Time required for the first analgesia;Incidence of nausea and vomiting;

Countries

China

Contacts

Public ContactLiuqing Yuan

The First Affiliated Hospital of Gannan Medical College

jiaxing202010@163.com+86 13576745474

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026